One of the issues frequently popping up in debates about synthetic biology (synbio) is the possibility of introducing new and yet unknown types of biological risks.
Citizen Health Innovators are increasingly equipped with the crowdfunding tools to shape their own medical futures; but will societal and regulatory conditions give them legitimacy?
ETC Group has developed an online searchable database of 'GMO 2.0’ ingre-dients. The beta version of 'GMO 2.0 database’ was launched at Natural Products Expo West 2017 in California and is now openly available for general testing.
In April 2017 BACH-BERRY launched BerryMaker – an exciting science game exploring the world of synthetic biology and berries
In May 2017 the Public Engagement Team from the University of Bristol will launch an International Online Dialogue designed to help surface the concerns and views of young people aged 11-25 on synthetic biolog
Notions of ‘Responsible Research and Innovation’ (RRI) or ‘Responsible Innovation’ have evolved over at least ten years, both in the EU and the US.
The last weekend of October 2016, I was at the Giant Jamboree in Boston, USA, to meet as many members of the iGEM community as possible and present them with a tool we developed for them in order to support the community for a respons
Doing It Together Science (DITOs) will implement many innovative participatory event formats across Europe focusing on the active involvement of citizens in two critical areas: the cutting edge topic of biodesign and the pressing area of envir
In the past years, there has been a growing interest within the art and design community to engage with life sciences—from growing biomaterials (i.e., make mycelium furniture) to designing genetic circuits (i.e., explore bacterial photography)
On October 27-31 the international Genetic Engineering Machine competition (iGEM) welcomed 3,000 attendees to Boston for the Giant Jamboree, the annual gathering of students presenting their projects.
Making_Life was a project about art and synthetic biology organized by the Finnish Bioartsociety in Helsinki.
What is the future of biotechnology? How can we create an ecosystem that integrates traditional and non-traditional actors and bolsters innovation?
Synthetic biology (synbio) is a very young and still unconsolidated new emerging technology.
On 14-15 January 2016, the European Economic and Social Committee (EESC) hosted the joint final event of 4 European projects, all working with the concept of RRI.
Standards are traditionally claimed to be one of the pillars of modern Engineering and as such they are also vindicated as one of the core tenets of contemporary Synthetic Biology.
The mutual learning activities between iGEM and SYNENERGENE were continued this year, as we again called the iGEM teams to reflect on the societal ramifications of their projects by creating two types of scenarios.
In Mid-September, a public dialogue event initiated and organised by a SYNENERGENE mini consortium took place in Karlsruhe.
Synthetic biology is already being used in the processing of biomass to produce industrial goods such as biofuels, commodities for the chemical industry and ingredients for consumer goods.
Late November 2015, a group of scientists from the University of California announced their plans in Proceedings of the National Academy of Sciences to use gene drive technology to engineer a whole population of the mosquito that normally carry th
Recently developed technology to make morphine and other opiates from glucose with synbio-engineered yeast may have an advantage in terms of cost-effectiveness, secureness, safety and decreased addictiveness compared with conventional opiates prod
On February 17, 2015, 60 people on three continents started participating in the first BioHack Academy organised by De Waag in Amsterdam. They could follow lectures that were given and recorded every week.
Imagine it is 2035.
SYNENERGENE is a citizen dialogue and stakeholder networking project on synthetic biology (SynBio) with 25+ partners, involving stakeholders from science, industry, civil society, policy, art and other areas.
The annual international Genetically Engineered Machines student competition iGEM is a perfect match with SYNENERGENE.
Claire Marris’ article, “Synthetic biology’s malaria promises could backfire,” posits that synthetic biologists—by using semi-synthetic artemisinin as a prime example of why synthetic biology is important—are repeating history and, in doing so, re